IN2014CH00062A - - Google Patents

Info

Publication number
IN2014CH00062A
IN2014CH00062A IN62CH2014A IN2014CH00062A IN 2014CH00062 A IN2014CH00062 A IN 2014CH00062A IN 62CH2014 A IN62CH2014 A IN 62CH2014A IN 2014CH00062 A IN2014CH00062 A IN 2014CH00062A
Authority
IN
India
Prior art keywords
compositions
optionally
carbapenem
stabilizer
therapy
Prior art date
Application number
Other languages
English (en)
Inventor
Alagarsamy Alagumurugan
Basak Sachinandan
Priya Shanmuga
Agrawal Sudeep
Louis Amari
Original Assignee
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospira Inc filed Critical Hospira Inc
Priority to IN62CH2014 priority Critical patent/IN2014CH00062A/en
Priority to PCT/US2014/072996 priority patent/WO2015105720A1/en
Publication of IN2014CH00062A publication Critical patent/IN2014CH00062A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
IN62CH2014 2014-01-07 2014-12-31 IN2014CH00062A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN62CH2014 IN2014CH00062A (ja) 2014-01-07 2014-12-31
PCT/US2014/072996 WO2015105720A1 (en) 2014-01-07 2014-12-31 Stabilised carbapenem compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN62CH2014 IN2014CH00062A (ja) 2014-01-07 2014-12-31

Publications (1)

Publication Number Publication Date
IN2014CH00062A true IN2014CH00062A (ja) 2015-07-10

Family

ID=53524262

Family Applications (1)

Application Number Title Priority Date Filing Date
IN62CH2014 IN2014CH00062A (ja) 2014-01-07 2014-12-31

Country Status (2)

Country Link
IN (1) IN2014CH00062A (ja)
WO (1) WO2015105720A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114224854A (zh) * 2022-02-14 2022-03-25 成都晶富医药科技有限公司 注射用厄他培南及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
CN102026621A (zh) * 2008-05-15 2011-04-20 巴克斯特国际公司 稳定的药物制剂
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术(石家庄)有限公司 一种厄他培南钠晶型及其制备方法

Also Published As

Publication number Publication date
WO2015105720A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
PH12016501512A1 (en) Treatment for resistant acne
MX2016002571A (es) Regulador de ph de transduccion.
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
MX2017001279A (es) Usos y composiciones de la flagelina.
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
MX2017009720A (es) Composiciones de oligosacaridos para el uso en composiciones nutricionales y metodos para producirlas.
MX2015010191A (es) Metodos para tratar infecciones microbianas, incluyendo mastitis.
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MX2017006026A (es) Apilimod para uso en el tratamiento de cancer colorrectal.
PH12016500495A1 (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
AU2016356504A8 (en) 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
PH12018500358A1 (en) Compounds for use in an antibacterial applications
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
MX2017013879A (es) Composiciones que comprenden anakinra.
MX2017006138A (es) Composiciones farmaceuticas de accion prolongada para hepatitis c.
IN2014CH00062A (ja)
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis